Asthma
📧 Sign up to get email alerts when something new happens for Asthma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2023-05-22Clinical Trial Update: Effect of Clopidogrel on Allergen Challenge in Asthma [Phase 2]
Phase 2 clinical trial assessing the effect of clopidogrel on allergen-induced airway responses in asthma has completed.
-
CLINICAL_TRIALS trial_result · 2023-05-19Clinical Trial Update: A 3-week Study Investigating Patient Use and Functionality of Formoterol in a Novel Inhalation Device in Patients With Asthma [Phase 3]
A completed Phase 3 trial evaluating patient use and functionality of formoterol delivered by a novel inhalation device in asthma patients.
-
CLINICAL_TRIALS trial_result · 2023-05-19Clinical Trial Update: Effectiveness of the Aeroneb in Acute Severe Asthma [NA]
Clinical trial update on the Aeroneb device for acute severe asthma; study completed with results posted in 2023.
-
CLINICAL_TRIALS research · 2023-05-15Clinical Trial Update: A Comparison of Critical Errors, Overall Errors, Training/Teaching Time, and Preference Attributes of the ELLIPTA Versus BREEZHALER Dry Powder Inhalers (DPIs) in Adult Participants With Asthma [Phase 4]
Phase 4 trial comparing ELLIPTA and BREEZHALER dry powder inhalers in adults with asthma; focuses on errors, training time, and user prefere…
-
FDA approval · 2023-05-12FDA Approved: BREO ELLIPTA — Supplemental Application (GlaxoSmithKline LLC)
FDA approved a supplemental application for BREO ELLIPTA submitted by GlaxoSmithKline. The approval pertains to changes to the product's lab…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA label_change · 2023-05-10FDA Approved: METHYLPREDNISOLONE ACETATE — Supplemental Application (Sandoz Inc.)
FDA approved a supplemental application for methylprednisolone acetate by Sandoz Inc.
-
CLINICAL_TRIALS trial_result · 2023-05-10Clinical Trial Update: The PEBBLES Study - Testing a Strategy for Preventing Eczema and Food Allergy in High Risk Infants [Phase 3]
Phase 3 trial update for the PEBBLES study evaluating a preventive strategy for eczema and food allergy in high-risk infants.
-
FDA approval · 2023-05-08FDA Approved: ALBUTEROL SULFATE — Supplemental Application (Mylan Pharmaceuticals Inc.)
The FDA approved a supplemental application for albuterol sulfate submitted by Mylan Pharmaceuticals Inc. under ANDA214531. This action adds…
-
CLINICAL_TRIALS trial_result · 2023-05-06Clinical Trial Update: Symptom Perception [NA]
Clinical trial update for Symptom Perception in asthma; the study is completed with results posted in 2023.
-
FDA approval · 2023-04-26FDA Approved: THEOPHYLLINE — Original Application (Bionpharma Inc.,)
FDA approves Bionpharma Inc.’s Theophylline generic under an Original Application (ANDA). The product is approved for use in asthma and chro…
-
CLINICAL_TRIALS research · 2023-04-25Clinical Trial Update: Mechanisms of Adverse Effects of Long-Acting Beta-Agonists in Asthma [Phase 4]
A Phase 4 clinical trial investigating mechanisms underlying adverse effects of long-acting beta-agonists in asthma.
-
CLINICAL_TRIALS trial_result · 2023-04-21Clinical Trial Update: Study to Assess the Effect of Tezepelumab on the Immune Response to Influenza Vaccination in Participants With Asthma [Phase 3]
Phase 3 study assessing tezepelumab's effect on immune response to influenza vaccination in adults with moderate to severe asthma has comple…
-
CLINICAL_TRIALS trial_result · 2023-04-21Clinical Trial Update: Evaluating Long Acting Beta Agonists Used to Treat Asthma Among Those With Either Arg/Arg or Gly/Gly Genotypes [NA]
A completed clinical trial evaluating long-acting beta agonists for asthma stratified by Arg/Arg or Gly/Gly genotypes; results posted in 202…
-
CLINICAL_TRIALS trial_result · 2023-04-19Clinical Trial Update: Vitamin D Oral Replacement in Asthma [NA]
Completed clinical trial evaluating oral vitamin D replacement in pediatric asthma patients with vitamin D deficiency.
-
CLINICAL_TRIALS trial_result · 2023-04-18Clinical Trial Update: Protein Biomarker Discovery and Validation in Chronic Obstructive Pulmonary Disease (COPD) And Asthma
A terminated clinical trial focusing on protein biomarker discovery and validation in asthma and COPD, with results posted in 2023.
-
FDA approval · 2023-04-12FDA Approved: LEVALBUTEROL — Supplemental Application (Mylan Pharmaceuticals Inc.)
FDA approved a supplemental application for levalbuterol by Mylan Pharmaceuticals, approving a change to the product under ANDA 078309.
-
FDA approval · 2023-04-12FDA Approved: BUDESONIDE — Original Application (Padagis Israel Pharmaceuticals Ltd)
FDA approved the original application for Budesonide from Padagis Israel Pharmaceuticals Ltd, granting a generic version of budesonide. The …
-
CLINICAL_TRIALS trial_result · 2023-04-07Clinical Trial Update: The Study is Enrolling Kids From 8 to 17 Years Old. The BreathSmart Device Attaches to the Inhaler to Measure Adherence. [NA]
A completed pediatric asthma trial evaluating a BreathSmart device that attaches to an inhaler to measure adherence in ages 8-17.
-
CLINICAL_TRIALS trial_result · 2023-04-06Clinical Trial Update: A Clinical Trial for Examining the Therapeutic Equivalence Between Fluticasone Propionate 100 mcg/Blister Oral Inhalation Powder/Respirent Pharmaceuticals vs. FLOVENT DISKUS® 100mcg/Blister Oral Inhalation Powder/GSK in Patients With Asthma [Phase 3]
Phase 3 trial evaluating therapeutic equivalence between Respirent Fluticasone Propionate 100 mcg inhalation powder and GlaxoSmithKline FLOV…
-
CLINICAL_TRIALS trial_result · 2023-03-31Clinical Trial Update: Fluticasone-Vilanterol Once Daily Dose for the Treatment of Mild Asthma in Adults [Phase 2, Phase 3]
A clinical trial update for a fluticasone-vilanterol combination dosed once daily in adults with mild asthma, covering Phase 2 and Phase 3 r…
-
CLINICAL_TRIALS trial_result · 2023-03-30Clinical Trial Update: Use of Dexamethasone in Pediatric Asthma Exacerbations [Phase 3]
Phase 3 trial update on dexamethasone use in pediatric asthma exacerbations has completed with posted results.
-
CLINICAL_TRIALS trial_result · 2023-03-27Clinical Trial Update: Ginger's Therapeutic Potential in Asthma [EARLY_Phase 1]
Early-phase1 clinical trial evaluating ginger's therapeutic potential in asthma has completed with results posted.
-
FDA approval · 2023-03-22FDA Approved: FORMOTEROL FUMARATE — Original Application (Lifestar Pharma LLC)
FDA approves the original application for Formoterol fumarate dihydrate supplied by Lifestar Pharma LLC. This generic product is approved fo…
-
FDA approval · 2023-03-20FDA Approved: THEOPHYLLINE — Original Application (Amneal Pharmaceuticals NY LLC)
FDA approved Amneal's Theophylline (generic) under an Original Application (ANDA 216276). Theophylline is indicated for relief of bronchospa…
-
FDA approval · 2023-03-17FDA Approved: XOLAIR — Supplemental Application (Genentech, Inc.)
FDA approved a supplemental application for XOLAIR (omalizumab) submitted by Genentech, Inc., representing an additional regulatory action f…